BDBM50168287 CHEMBL363800::Sodium; {3-[(1R,2S,6S)-1-(4,5-diphenyl-oxazol-2-yl)-7-oxa-bicyclo[4.1.0]hept-2-ylmethyl]-phenoxy}-acetate

SMILES [O-]C(=O)COc1cccc(C[C@@H]2CCC[C@@H]3O[C@]23c2nc(c(o2)-c2ccccc2)-c2ccccc2)c1

InChI Key InChIKey=XQSDEHHCLDLVST-JCAOREMYSA-M

Data  8 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50168287   

TargetProstacyclin receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi:  6.10nMAssay Description:Inhibition of [3H]-Iloprost binding to human Prostanoid IP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane A2 receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi:  930nMAssay Description:Inhibition of [3H]-SQ-29,548 binding to human Prostanoid TP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi:  1.40E+3nMAssay Description:Inhibition of [3H]-PGE-2 binding to Prostanoid EP2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin D2 receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi:  2.90E+3nMAssay Description:Inhibition of [3H]-PGD-2 binding to human Prostanoid DP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi:  3.20E+3nMAssay Description:Inhibition of [3H]-PGE-2 binding to Prostanoid EP3 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi:  7.20E+3nMAssay Description:Inhibition of [3H]-PGE-2 binding to Prostanoid EP4 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi: >1.00E+4nMAssay Description:Inhibition of [3H]-PGE-2 binding to Prostanoid EP1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50168287(CHEMBL363800 | Sodium; {3-[(1R,2S,6S)-1-(4,5-diphe...)
Affinity DataKi: >1.00E+4nMAssay Description:Inhibition of [3H]-PGF-2 binding to human Prostanoid FP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed